Other Species / Isoforms
  RIAM (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y45
PPREEFNYTVGFKDL
1 63
RIAM (human) PPRAEFNySVGFKDL Y45-p
RIAM (mouse) PPREEFNYTVGFKDL Y45
RIAM (rat) PPREEFNFSVGFKDL F45
S55-p
GFKDLNEsLNALEDQ
Upstream
0 3
Treatment
  • IFN-gamma
RIAM (human) GFKDLNEsLNALEDQ S55-p
RIAM (mouse) GFKDLNEsLNALEDQ S55-p
RIAM (rat) GFKDLNESLNALEDQ S55
K167
KAKADKIKLALEKLK
0 2
RIAM (human) QAKADKIkLALEkLK K164-ub
RIAM (mouse) KAKADKIKLALEKLK K167
RIAM (rat) LAKADKIKLALEKLK K166
K172
KIKLALEKLKEAKVK
0 1
RIAM (human) KIkLALEkLKEAKVK K169-ub
RIAM (mouse) KIKLALEKLKEAKVK K172
RIAM (rat) KIKLALEKLKEAKVK K171
K184
KVKKLVVKVHMDDSS
0 1
RIAM (human) KVKKLVVkVHMNDNS K181-ub
RIAM (mouse) KVKKLVVKVHMDDSS K184
RIAM (rat) KVKKLVVKVHMGDNS K183
K193
HMDDSSTKSLMVDER
0 2
RIAM (human) HMNDNSTkSLMVDER K190-ub
RIAM (mouse) HMDDSSTKSLMVDER K193
RIAM (rat) HMGDNSTKSLMVDER K192
K213
VLDNLFEKTHCDCNV
0 1
RIAM (human) VLDNLFEkTHCDCNV K210-ub
RIAM (mouse) VLDNLFEKTHCDCNV K213
RIAM (rat) VLDNLFEKTHCDCNV K212
Y228-p
DWCLYEIyPELQIER
0 7
RIAM (human) DWCLYEIyPELQIER Y225-p
RIAM (mouse) DWCLYEIyPELQIER Y228-p
RIAM (rat) DWCLYEIYPELQIER Y227
K257-ub
WTRDTENkVLFLEKE
0 3
RIAM (human) WTRDTENkILFLEkE K254-ub
RIAM (mouse) WTRDTENkVLFLEKE K257-ub
RIAM (rat) WTRDTENRVLFLEKE R256
K263
NkVLFLEKEERyAVF
0 3
RIAM (human) NkILFLEkEEKYAVF K260-ub
RIAM (mouse) NkVLFLEKEERyAVF K263
RIAM (rat) NRVLFLEKEEKYAVF K262
Y267-p
FLEKEERyAVFKNPQ
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, induced
  • intracellular localization
Effects on Biological Processes:
  • cell adhesion, induced
Kinase, in vitro:
  • Fyn (mouse)
  • Lck (mouse)
RIAM (human) FLEkEEKYAVFkNPQ Y264
RIAM (mouse) FLEKEERyAVFKNPQ Y267-p
RIAM (rat) FLEKEEKYAVFKNPQ Y266
K271
EERyAVFKNPQNFYL
0 4
RIAM (human) EEKYAVFkNPQNFyL K268-ub
RIAM (mouse) EERyAVFKNPQNFYL K271
RIAM (rat) EEKYAVFKNPQNFYL K270
Y277
FKNPQNFYLDNKGKK
0 44
RIAM (human) FkNPQNFyLDNRGKK Y274-p
RIAM (mouse) FKNPQNFYLDNKGKK Y277
RIAM (rat) FKNPQNFYLDNKGKK Y276
Y334-p
KKSWKRRyFLLRAsG
0 2
RIAM (human) KKSWKRRyFLLRAsG Y331-p
RIAM (mouse) KKSWKRRyFLLRAsG Y334-p
RIAM (rat) KKSWKRRYFLLRASG Y332
S340-p
RyFLLRAsGIyYVPK
0 2
RIAM (human) RyFLLRAsGIyyVPK S337-p
RIAM (mouse) RyFLLRAsGIyYVPK S340-p
RIAM (rat) RYFLLRASGIYYVPK S338
Y343-p
LLRAsGIyYVPKGKT
0 16
RIAM (human) LLRAsGIyyVPKGKT Y340-p
RIAM (mouse) LLRAsGIyYVPKGKT Y343-p
RIAM (rat) LLRASGIYYVPKGKT Y341
Y344
LRAsGIyYVPKGKTK
0 1
RIAM (human) LRAsGIyyVPKGKTK Y341-p
RIAM (mouse) LRAsGIyYVPKGKTK Y344
RIAM (rat) LRASGIYYVPKGKTK Y342
K378
IQCKMKYKAPTDHCF
0 3
RIAM (human) TQHKMKYkAPTDyCF K375-ub
RIAM (mouse) IQCKMKYKAPTDHCF K378
RIAM (rat) IQCKMKYKAPTDHCF K376
H383
KYKAPTDHCFVLKHP
0 22
RIAM (human) KYkAPTDyCFVLkHP Y380-p
RIAM (mouse) KYKAPTDHCFVLKHP H383
RIAM (rat) KYKAPTDHCFVLKHP H381
K388
TDHCFVLKHPQIQKE
0 2
RIAM (human) TDyCFVLkHPQIQkE K385-ub
RIAM (mouse) TDHCFVLKHPQIQKE K388
RIAM (rat) TDHCFVLKHPQIQKE K386
K394
LKHPQIQKESQYIKY
0 3
RIAM (human) LkHPQIQkESQYIkY K391-ub
RIAM (mouse) LKHPQIQKESQYIKY K394
RIAM (rat) LKHPQIQKESQYIKY K392
K400
QKESQYIKYLCCDDA
0 2
RIAM (human) QkESQYIkYLCCDDT K397-ub
RIAM (mouse) QKESQYIKYLCCDDA K400
RIAM (rat) QKESQYIKYLCCDDA K398
K424
IRIAKYGKTLyDNYQ
0 3
RIAM (human) IRIAKYGkTLYDNYQ K421-ub
RIAM (mouse) IRIAKYGKTLyDNYQ K424
RIAM (rat) IRIAKYGKTLYDNYQ K422
Y427-p
AKYGKTLyDNYQRAV
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, induced
  • intracellular localization
Effects on Biological Processes:
  • cell adhesion, induced
Kinase, in vitro:
  • Fyn (mouse)
  • Lck (mouse)
RIAM (human) AKYGkTLYDNYQRAV Y424
RIAM (mouse) AKYGKTLyDNYQRAV Y427-p
RIAM (rat) AKYGKTLYDNYQRAV Y425
R436
NYQRAVARAGLASRW
0 3
RIAM (human) NYQRAVAkAGLASRW K433-ub
RIAM (mouse) NYQRAVARAGLASRW R436
RIAM (rat) NYQRAVARAGLASRW R434
S507-p
KQGLGNHsPGATREN
Upstream
0 18
Treatment
  • LPS
RIAM (human) PALGNHHDPAVPRAP D502
RIAM (mouse) KQGLGNHsPGATREN S507-p
RIAM (rat) KQGLANHsPGASREN S500-p
S531-p
PPPPVRRssDtCGsP
0 11
RIAM (human) PPPPVRRssDtsGsP S525-p
RIAM (mouse) PPPPVRRssDtCGsP S531-p
RIAM (rat) PPPPVRRSSDTCGSP S524
S532-p
PPPVRRssDtCGsPA
Upstream
0 106
Treatment
  • insulin
  • LPS
  • LY294002
  • PTH(1-34)
RIAM (human) PPPVRRssDtsGsPA S526-p
RIAM (mouse) PPPVRRssDtCGsPA S532-p
RIAM (rat) PPPVRRSSDTCGSPA S525
T534-p
PVRRssDtCGsPALP
0 21
RIAM (human) PVRRssDtsGsPAtP T528-p
RIAM (mouse) PVRRssDtCGsPALP T534-p
RIAM (rat) PVRRSSDTCGSPALP T527
C535
VRRssDtCGsPALPS
0 6
RIAM (human) VRRssDtsGsPAtPL S529-p
RIAM (mouse) VRRssDtCGsPALPS C535
RIAM (rat) VRRSSDTCGSPALPP C528
S537-p
RssDtCGsPALPSKV
Upstream
0 31
Treatment
  • insulin
  • ischemia
RIAM (human) RssDtsGsPAtPLKA S531-p
RIAM (mouse) RssDtCGsPALPSKV S537-p
RIAM (rat) RSSDTCGSPALPPKA S530
L540
DtCGsPALPSKVKGP
0 58
RIAM (human) DtsGsPAtPLKAKGT T534-p
RIAM (mouse) DtCGsPALPSKVKGP L540
RIAM (rat) DTCGSPALPPKAKGP L533
S623-p
LSQEITKsSPLPPKK
Upstream
0 1
Treatment
  • LPS
RIAM (human) PAPAPVPDSARPPPA D615
RIAM (mouse) LSQEITKsSPLPPKK S623-p
RIAM (rat) LSQEMTKSSPLPAKK S617
S656
NSEQDFMSDLMKALQ
0 1
RIAM (human) GGEQDFMsDLMKALQ S652-p
RIAM (mouse) NSEQDFMSDLMKALQ S656
RIAM (rat) NTEQDFMSDLMKALQ S650